Metabolic & Weight Management

Researchers looking to buy metabolic research peptides at verified analytical purity will find Advanced Peptide Science’s Metabolic & Weight Management catalogue covers the major incretin and lipolytic compound classes used in contemporary preclinical metabolic investigation. Each compound is supplied as lyophilized powder at 99%+ HPLC-verified purity for in vitro and in vivo research applications.This category includes Tirzepatide, a dual GLP-1/GIP receptor agonist studied for incretin signalling research; Semaglutide, a long-acting GLP-1 receptor agonist; and Retatrutide, an investigational triple-agonist targeting GLP-1, GIP, and glucagon receptors. The category also stocks Liraglutide for acute GLP-1 receptor activation studies, AOD-9604, the C-terminal hGH fragment investigated for lipolytic mechanism research, and the orally bioavailable 5-Amino-1MQ, a small-molecule NNMT inhibitor used in NAD+ pathway and adipocyte metabolism studies.All compounds in this category are independently verified by third-party analytical laboratories. Batch-specific Certificates of Analysis confirming 99%+ purity via HPLC are available upon request at research@advancedpeptidescience.com. Reconstitution requires Bacteriostatic Water 30ml for injectable compounds.For Research Use Only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.Related ResearchWhat is Tirzepatide? A Complete GIP/GLP-1 Research Overview 2026Semaglutide vs Tirzepatide vs Retatrutide: Incretin Research ComparisonRetatrutide: The Triple Agonist Redefining Metabolic Research in 2026AOD-9604 Peptide: HGH Fragment Lipolysis Research Overview5-Amino-1MQ: NNMT Inhibition and NAD+ Pathway ResearchGLP-1 Peptides for Research: The Complete 2026 Scientific OverviewLiraglutide vs Semaglutide: First vs Second Generation GLP-1 Research